Biomedical Engineering Reference
In-Depth Information
TABLE 11.2.
(Continued
)
Substrate
a
Drug Resistance
b
K
m
(
μ
M)
Refs.
Refs.
Chenodeoxycholylglycine
(
+
GSH)
d
5.9
123
Chenodeoxycholyltaurine
(
+
GSH)
d
3.6
123
Ursodeoxycholylglycine
(
+
GSH)
d
12.5
123
Ursodeoxycholyltaurine
(
+
GSH)
d
7.8
123
ADP
118
ABCC5
cGMP
e
55
Cadmium chloride
54
cAMP
e
55
Potassium antimonyl
54
5-Fluoro-2
-deoxyuridine
monophosphate
1100
127
6-Mercaptopurine
56
5-Fluorouridine
monophosphate
127
6-Thioguanine
56,127
2
-Deoxyuridine
monophosphate
127
PMEA
e
56
Folate
1000
128
5-Fluorouracil
127
Methotrexate
1300
128
Methotrexate
127,128
Diglutamylated
methotrexate
700
128
ABCC6
BQ-123
57,58
Etoposide
57
Leukotriene C
4
∼
0.6
57,58
Teniposide
57
S
-Glutathionyl
N
-ethylmaleimide
∼
282
58
S
-Glutathionyl
2,4-dinitrobenzene
57
ABCC10
17
β
-Glucuronosyl
estradiol
58
129
Docetaxel
130
Leukotriene C
4
129
Paclitaxel
130
Vincristine
130
Vinblastine
130
ABCC11
5-Fluoro-2
-deoxyuridine
monophosphate
131
5-Fluorouracil
131
Dehydroepiandrosterone
3-sulfate
13
60,132
5-Fluoro-2
-deoxyuridine
131
Estrone 3-sulfate
>
150
60,132
5-Fluoro-5
-deoxyuridine
131
Leukotriene C
4
132
2
,3
-Dideoxycytidine
131
(
Continued
)
Search WWH ::
Custom Search